Artelo Historical Cash Flow
| ARTL Stock | USD 1.16 0.01 0.85% |
Analysis of Artelo Biosciences cash flow over time is an excellent tool to project Artelo Biosciences future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 0.0 or Total Cash From Financing Activities of 619.4 K as it is a great indicator of Artelo Biosciences ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Artelo Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Artelo Biosciences is a good buy for the upcoming year.
Artelo |
About Artelo Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Artelo balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Artelo's non-liquid assets can be easily converted into cash.
Artelo Biosciences Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Artelo Biosciences' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Artelo Biosciences current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Artelo Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.At this time, Artelo Biosciences' Depreciation is quite stable compared to the past year.
| 2022 | 2023 | 2024 | 2025 (projected) | Issuance Of Capital Stock | 535K | 567K | 510.3K | 484.8K | Stock Based Compensation | 2.5M | 1.0M | 1.2M | 959.4K |
Artelo Biosciences cash flow statement Correlations
Click cells to compare fundamentals
Artelo Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Artelo Biosciences cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | (2.3M) | 4.5M | (5.3M) | (4.1M) | (3.7M) | (3.5M) | |
| Net Borrowings | 1.8K | 1.0K | 3.2K | (7K) | (6.3K) | (6.0K) | |
| Free Cash Flow | (4.3M) | (6.1M) | (8.0M) | (8.2M) | (7.4M) | (7.0M) | |
| Change In Working Capital | (41.3K) | (242K) | (172K) | 703K | 808.5K | 848.9K | |
| Other Non Cash Items | 100K | (29.5K) | 7K | (211K) | (189.9K) | (180.4K) | |
| Total Cash From Operating Activities | (4.3M) | (6.1M) | (8.0M) | (8.2M) | (7.4M) | (7.0M) | |
| Change To Operating Activities | (35.4K) | 27.0K | (169.3K) | (241K) | (216.9K) | (206.1K) | |
| Net Income | (4.7M) | (7.4M) | (10.1M) | (9.3M) | (8.4M) | (7.9M) | |
| Total Cash From Financing Activities | 2.0M | 14.1M | (43K) | 567K | 652.1K | 619.4K | |
| End Period Cash Flow | 2.1M | 6.6M | 6.9M | 2.8M | 3.2M | 2.6M | |
| Change To Netincome | 290.0K | (481.0K) | 348.3K | 1.5M | 1.8M | 1.9M | |
| Change To Liabilities | 500.7K | (180.4K) | 128.0K | (3K) | (3.5K) | (3.3K) | |
| Sale Purchase Of Stock | 1.4M | 8.4M | (108.0) | 9.0 | 10.35 | 9.83 | |
| Begin Period Cash Flow | 4.4M | 2.1M | 12.2M | 6.9M | 7.9M | 8.3M | |
| Other Cashflows From Financing Activities | 1.0K | 3.2K | 6.0M | 3.0M | 3.4M | 3.6M | |
| Stock Based Compensation | 377.8K | 1.5M | 2.5M | 1.0M | 1.2M | 959.4K | |
| Issuance Of Capital Stock | 2.0M | 8.1M | 535K | 567K | 510.3K | 484.8K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Artelo Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Artelo Biosciences. If investors know Artelo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Artelo Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Artelo Biosciences is measured differently than its book value, which is the value of Artelo that is recorded on the company's balance sheet. Investors also form their own opinion of Artelo Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Artelo Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Artelo Biosciences' market value can be influenced by many factors that don't directly affect Artelo Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Artelo Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Artelo Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Artelo Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.